These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28527688)

  • 21. Impact of placental Plasmodium falciparum malaria infection on the Cameroonian maternal and neonate's plasma levels of some cytokines known to regulate T cells differentiation and function.
    Djontu JC; Siewe Siewe S; Mpeke Edene YD; Nana BC; Chomga Foko EV; Bigoga JD; Leke RF; Megnekou R
    Malar J; 2016 Nov; 15(1):561. PubMed ID: 27871325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of adjuvants on the immune response induced by a DBL4ɛ-ID4 VAR2CSA based Plasmodium falciparum vaccine against placental malaria.
    Pinto VV; Salanti A; Joergensen LM; Dahlbäck M; Resende M; Ditlev SB; Agger EM; Arnot DE; Theander TG; Nielsen MA
    Vaccine; 2012 Jan; 30(3):572-9. PubMed ID: 22122859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
    Nielsen MA; Resende M; de Jongh WA; Ditlev SB; Mordmüller B; Houard S; Ndam NT; Agerbæk MØ; Hamborg M; Massougbodji A; Issifou S; Strøbæk A; Poulsen L; Leroy O; Kremsner PG; Chippaux JP; Luty AJ; Deloron P; Theander TG; Dyring C; Salanti A
    PLoS One; 2015; 10(9):e0135406. PubMed ID: 26327283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.
    Bordbar B; Tuikue Ndam N; Renard E; Jafari-Guemouri S; Tavul L; Jennison C; Gnidehou S; Tahar R; Gamboa D; Bendezu J; Menard D; Barry AE; Deloron P; Sabbagh A
    Infect Genet Evol; 2014 Jul; 25():81-92. PubMed ID: 24768682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA.
    Barfod L; Bernasconi NL; Dahlbäck M; Jarrossay D; Andersen PH; Salanti A; Ofori MF; Turner L; Resende M; Nielsen MA; Theander TG; Sallusto F; Lanzavecchia A; Hviid L
    Mol Microbiol; 2007 Jan; 63(2):335-47. PubMed ID: 17176260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a vaccine against pregnancy-associated malaria.
    Tuikue Ndam N; Deloron P
    Parasite; 2008 Sep; 15(3):515-21. PubMed ID: 18814733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities.
    Ndam NT; Mbuba E; González R; Cisteró P; Kariuki S; Sevene E; Rupérez M; Fonseca AM; Vala A; Maculuve S; Jiménez A; Quintó L; Ouma P; Ramharter M; Aponte JJ; Nhacolo A; Massougbodji A; Briand V; Kremsner PG; Mombo-Ngoma G; Desai M; Macete E; Cot M; Menéndez C; Mayor A
    BMC Med; 2017 Jul; 15(1):130. PubMed ID: 28712360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mother-Newborn Pairs in Malawi Have Similar Antibody Repertoires to Diverse Malaria Antigens.
    Boudová S; Walldorf JA; Bailey JA; Divala T; Mungwira R; Mawindo P; Pablo J; Jasinskas A; Nakajima R; Ouattara A; Adams M; Felgner PL; Plowe CV; Travassos MA; Laufer MK
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28835359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.
    Luty AJ; Bongartz M; Rezbach P; Faucher JF; Hollingdale MR; Kremsner PG
    Eur Cytokine Netw; 2001; 12(4):647-53. PubMed ID: 11781192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
    Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
    Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
    Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
    Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.
    Ibitokou SA; Denoeud-Ndam L; Ezinmegnon S; Ladékpo R; Zannou DM; Massougbodji A; Girard PM; Cot M; Luty AJ; Ndam NT
    Am J Trop Med Hyg; 2015 Aug; 93(2):287-92. PubMed ID: 26101276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
    Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
    Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
    Troye-Blomberg M; Olerup O; Perlmann H; Larsson A; Elghazali G; Fogdell A; Jepsen A; Lepers JP; Pandey JP; Grunewald J
    Behring Inst Mitt; 1994 Dec; (95):97-105. PubMed ID: 7755513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High production of pro-inflammatory cytokines by maternal blood mononuclear cells is associated with reduced maternal malaria but increased cord blood infection.
    Dobaño C; Berthoud T; Manaca MN; Nhabomba A; Guinovart C; Aguilar R; Barbosa A; Groves P; Rodríguez MH; Jimenez A; Quimice LM; Aponte JJ; Ordi J; Doolan DL; Mayor A; Alonso PL
    Malar J; 2018 May; 17(1):177. PubMed ID: 29743113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration.
    Dahlbäck M; Rask TS; Andersen PH; Nielsen MA; Ndam NT; Resende M; Turner L; Deloron P; Hviid L; Lund O; Pedersen AG; Theander TG; Salanti A
    PLoS Pathog; 2006 Nov; 2(11):e124. PubMed ID: 17112315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.